{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "98a8af1c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Brnd_Name</th>\n",
       "      <th>Gnrc_Name</th>\n",
       "      <th>Tot_Mftr</th>\n",
       "      <th>Mftr_Name</th>\n",
       "      <th>Tot_Spndng_2019</th>\n",
       "      <th>Tot_Dsg_Unts_2019</th>\n",
       "      <th>Tot_Clms_2019</th>\n",
       "      <th>Tot_Benes_2019</th>\n",
       "      <th>Avg_Spnd_Per_Dsg_Unt_Wghtd_2019</th>\n",
       "      <th>Avg_Spnd_Per_Clm_2019</th>\n",
       "      <th>...</th>\n",
       "      <th>Tot_Spndng_2023</th>\n",
       "      <th>Tot_Dsg_Unts_2023</th>\n",
       "      <th>Tot_Clms_2023</th>\n",
       "      <th>Tot_Benes_2023</th>\n",
       "      <th>Avg_Spnd_Per_Dsg_Unt_Wghtd_2023</th>\n",
       "      <th>Avg_Spnd_Per_Clm_2023</th>\n",
       "      <th>Avg_Spnd_Per_Bene_2023</th>\n",
       "      <th>Outlier_Flag_2023</th>\n",
       "      <th>Chg_Avg_Spnd_Per_Dsg_Unt_22_23</th>\n",
       "      <th>CAGR_Avg_Spnd_Per_Dsg_Unt_19_23</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1st Tier Unifine Pentips</td>\n",
       "      <td>Pen Needle, Diabetic</td>\n",
       "      <td>1</td>\n",
       "      <td>Overall</td>\n",
       "      <td>139201.68</td>\n",
       "      <td>642471.0</td>\n",
       "      <td>5392.0</td>\n",
       "      <td>1878.0</td>\n",
       "      <td>0.216788</td>\n",
       "      <td>25.816335</td>\n",
       "      <td>...</td>\n",
       "      <td>44355.04</td>\n",
       "      <td>195672.0</td>\n",
       "      <td>1613</td>\n",
       "      <td>699.0</td>\n",
       "      <td>0.227162</td>\n",
       "      <td>27.498475</td>\n",
       "      <td>63.454993</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.005702</td>\n",
       "      <td>0.011754</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1st Tier Unifine Pentips</td>\n",
       "      <td>Pen Needle, Diabetic</td>\n",
       "      <td>1</td>\n",
       "      <td>Owen Mumford Us</td>\n",
       "      <td>139201.68</td>\n",
       "      <td>642471.0</td>\n",
       "      <td>5392.0</td>\n",
       "      <td>1878.0</td>\n",
       "      <td>0.216788</td>\n",
       "      <td>25.816335</td>\n",
       "      <td>...</td>\n",
       "      <td>44355.04</td>\n",
       "      <td>195672.0</td>\n",
       "      <td>1613</td>\n",
       "      <td>699.0</td>\n",
       "      <td>0.227162</td>\n",
       "      <td>27.498475</td>\n",
       "      <td>63.454993</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.005702</td>\n",
       "      <td>0.011754</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1st Tier Unifine Pentips Plus</td>\n",
       "      <td>Pen Needle, Diabetic</td>\n",
       "      <td>1</td>\n",
       "      <td>Overall</td>\n",
       "      <td>343031.42</td>\n",
       "      <td>1830596.0</td>\n",
       "      <td>14581.0</td>\n",
       "      <td>5319.0</td>\n",
       "      <td>0.187389</td>\n",
       "      <td>23.525919</td>\n",
       "      <td>...</td>\n",
       "      <td>97951.18</td>\n",
       "      <td>406617.0</td>\n",
       "      <td>3269</td>\n",
       "      <td>1267.0</td>\n",
       "      <td>0.240932</td>\n",
       "      <td>29.963652</td>\n",
       "      <td>77.309534</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.022165</td>\n",
       "      <td>0.064848</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1st Tier Unifine Pentips Plus</td>\n",
       "      <td>Pen Needle, Diabetic</td>\n",
       "      <td>1</td>\n",
       "      <td>Owen Mumford Us</td>\n",
       "      <td>343031.42</td>\n",
       "      <td>1830596.0</td>\n",
       "      <td>14581.0</td>\n",
       "      <td>5319.0</td>\n",
       "      <td>0.187389</td>\n",
       "      <td>23.525919</td>\n",
       "      <td>...</td>\n",
       "      <td>97951.18</td>\n",
       "      <td>406617.0</td>\n",
       "      <td>3269</td>\n",
       "      <td>1267.0</td>\n",
       "      <td>0.240932</td>\n",
       "      <td>29.963652</td>\n",
       "      <td>77.309534</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.022165</td>\n",
       "      <td>0.064848</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Abacavir</td>\n",
       "      <td>Abacavir Sulfate</td>\n",
       "      <td>5</td>\n",
       "      <td>Overall</td>\n",
       "      <td>10110328.45</td>\n",
       "      <td>3316293.0</td>\n",
       "      <td>42629.0</td>\n",
       "      <td>6085.0</td>\n",
       "      <td>3.482725</td>\n",
       "      <td>237.170200</td>\n",
       "      <td>...</td>\n",
       "      <td>5287295.41</td>\n",
       "      <td>1648593.0</td>\n",
       "      <td>19632</td>\n",
       "      <td>2809.0</td>\n",
       "      <td>3.594357</td>\n",
       "      <td>269.320263</td>\n",
       "      <td>1882.269637</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-0.071481</td>\n",
       "      <td>0.007919</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã— 46 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                       Brnd_Name             Gnrc_Name  Tot_Mftr  \\\n",
       "0       1st Tier Unifine Pentips  Pen Needle, Diabetic         1   \n",
       "1       1st Tier Unifine Pentips  Pen Needle, Diabetic         1   \n",
       "2  1st Tier Unifine Pentips Plus  Pen Needle, Diabetic         1   \n",
       "3  1st Tier Unifine Pentips Plus  Pen Needle, Diabetic         1   \n",
       "4                       Abacavir      Abacavir Sulfate         5   \n",
       "\n",
       "         Mftr_Name  Tot_Spndng_2019  Tot_Dsg_Unts_2019  Tot_Clms_2019  \\\n",
       "0          Overall        139201.68           642471.0         5392.0   \n",
       "1  Owen Mumford Us        139201.68           642471.0         5392.0   \n",
       "2          Overall        343031.42          1830596.0        14581.0   \n",
       "3  Owen Mumford Us        343031.42          1830596.0        14581.0   \n",
       "4          Overall      10110328.45          3316293.0        42629.0   \n",
       "\n",
       "   Tot_Benes_2019  Avg_Spnd_Per_Dsg_Unt_Wghtd_2019  Avg_Spnd_Per_Clm_2019  \\\n",
       "0          1878.0                         0.216788              25.816335   \n",
       "1          1878.0                         0.216788              25.816335   \n",
       "2          5319.0                         0.187389              23.525919   \n",
       "3          5319.0                         0.187389              23.525919   \n",
       "4          6085.0                         3.482725             237.170200   \n",
       "\n",
       "   ...  Tot_Spndng_2023  Tot_Dsg_Unts_2023  Tot_Clms_2023  Tot_Benes_2023  \\\n",
       "0  ...         44355.04           195672.0           1613           699.0   \n",
       "1  ...         44355.04           195672.0           1613           699.0   \n",
       "2  ...         97951.18           406617.0           3269          1267.0   \n",
       "3  ...         97951.18           406617.0           3269          1267.0   \n",
       "4  ...       5287295.41          1648593.0          19632          2809.0   \n",
       "\n",
       "   Avg_Spnd_Per_Dsg_Unt_Wghtd_2023  Avg_Spnd_Per_Clm_2023  \\\n",
       "0                         0.227162              27.498475   \n",
       "1                         0.227162              27.498475   \n",
       "2                         0.240932              29.963652   \n",
       "3                         0.240932              29.963652   \n",
       "4                         3.594357             269.320263   \n",
       "\n",
       "   Avg_Spnd_Per_Bene_2023  Outlier_Flag_2023  Chg_Avg_Spnd_Per_Dsg_Unt_22_23  \\\n",
       "0               63.454993                0.0                        0.005702   \n",
       "1               63.454993                0.0                        0.005702   \n",
       "2               77.309534                0.0                        0.022165   \n",
       "3               77.309534                0.0                        0.022165   \n",
       "4             1882.269637                0.0                       -0.071481   \n",
       "\n",
       "   CAGR_Avg_Spnd_Per_Dsg_Unt_19_23  \n",
       "0                         0.011754  \n",
       "1                         0.011754  \n",
       "2                         0.064848  \n",
       "3                         0.064848  \n",
       "4                         0.007919  \n",
       "\n",
       "[5 rows x 46 columns]"
      ]
     },
     "execution_count": 1,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "\n",
    "# Read the data \n",
    "\n",
    "file_path = 'Dataset/DSD_PTD_RY25_P04_V10_DY23_BGM.csv'\n",
    "\n",
    "csvFile = pd.read_csv(file_path)\n",
    "\n",
    "csvFile.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "abff356a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Brnd_Name', 'Gnrc_Name', 'Tot_Mftr', 'Mftr_Name', 'Tot_Spndng_2019',\n",
       "       'Tot_Dsg_Unts_2019', 'Tot_Clms_2019', 'Tot_Benes_2019',\n",
       "       'Avg_Spnd_Per_Dsg_Unt_Wghtd_2019', 'Avg_Spnd_Per_Clm_2019',\n",
       "       'Avg_Spnd_Per_Bene_2019', 'Outlier_Flag_2019', 'Tot_Spndng_2020',\n",
       "       'Tot_Dsg_Unts_2020', 'Tot_Clms_2020', 'Tot_Benes_2020',\n",
       "       'Avg_Spnd_Per_Dsg_Unt_Wghtd_2020', 'Avg_Spnd_Per_Clm_2020',\n",
       "       'Avg_Spnd_Per_Bene_2020', 'Outlier_Flag_2020', 'Tot_Spndng_2021',\n",
       "       'Tot_Dsg_Unts_2021', 'Tot_Clms_2021', 'Tot_Benes_2021',\n",
       "       'Avg_Spnd_Per_Dsg_Unt_Wghtd_2021', 'Avg_Spnd_Per_Clm_2021',\n",
       "       'Avg_Spnd_Per_Bene_2021', 'Outlier_Flag_2021', 'Tot_Spndng_2022',\n",
       "       'Tot_Dsg_Unts_2022', 'Tot_Clms_2022', 'Tot_Benes_2022',\n",
       "       'Avg_Spnd_Per_Dsg_Unt_Wghtd_2022', 'Avg_Spnd_Per_Clm_2022',\n",
       "       'Avg_Spnd_Per_Bene_2022', 'Outlier_Flag_2022', 'Tot_Spndng_2023',\n",
       "       'Tot_Dsg_Unts_2023', 'Tot_Clms_2023', 'Tot_Benes_2023',\n",
       "       'Avg_Spnd_Per_Dsg_Unt_Wghtd_2023', 'Avg_Spnd_Per_Clm_2023',\n",
       "       'Avg_Spnd_Per_Bene_2023', 'Outlier_Flag_2023',\n",
       "       'Chg_Avg_Spnd_Per_Dsg_Unt_22_23', 'CAGR_Avg_Spnd_Per_Dsg_Unt_19_23'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Explore the columns of this dataset\n",
    "\n",
    "csvFile.columns"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ec94c37d",
   "metadata": {},
   "source": [
    "KPIs to calculate:\n",
    "- price per dose unit (weighted) by year\n",
    "- spend per claim by year\n",
    "- YoY change and 2019-2023 CAGR in price per dose unit\n",
    "- manufacturer share of total spend\n",
    "- brand vs generic share and substitution ratio\n",
    "- outlier count and contribution to spend"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "45de1bf1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{2019: np.float64(1.69),\n",
       " 2020: np.float64(1.75),\n",
       " 2021: np.float64(1.88),\n",
       " 2022: np.float64(2.01),\n",
       " 2023: np.float64(2.21)}"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Price per dose unit (weighted) by year\n",
    "\n",
    "years = [2019, 2020, 2021, 2022, 2023]\n",
    "results = {}\n",
    "\n",
    "for year in years:\n",
    "   kpi= round(csvFile[f'Tot_Spndng_{year}'].sum()/csvFile[f'Tot_Dsg_Unts_{year}'].sum(), 2)\n",
    "   results[year] = kpi\n",
    "\n",
    "results\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "1356797d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "nan"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tlts = sum(csvFile['Tot_Clms_2019'])\n",
    "tlts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "a9fa212c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "np.float64(2875940518.0)"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "csvFile['Tot_Clms_2019'].sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "87f98778",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{2019: np.float64(124.44),\n",
       " 2020: np.float64(133.15),\n",
       " 2021: np.float64(143.58),\n",
       " 2022: np.float64(155.66),\n",
       " 2023: np.float64(170.57)}"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "results_claim = {}\n",
    "for year in years:\n",
    "    total_spending = csvFile[f'Tot_Spndng_{year}'].sum()\n",
    "    total_claims = csvFile[f'Tot_Clms_{year}'].sum()\n",
    "    spend_per_claim = round(total_spending / total_claims, 2)\n",
    "    results_claim[year] = spend_per_claim\n",
    "\n",
    "results_claim"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "bf31b614",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/wy/v92nv28111j7vk4ynsyxm2700000gn/T/ipykernel_3323/306519548.py:17: UserWarning: No artists with labels found to put in legend.  Note that artists whose label start with an underscore are ignored when legend() is called with no argument.\n",
      "  ax.legend()\n",
      "/var/folders/wy/v92nv28111j7vk4ynsyxm2700000gn/T/ipykernel_3323/306519548.py:18: UserWarning: FigureCanvasAgg is non-interactive, and thus cannot be shown\n",
      "  fig.show()\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Display the results in a bar chart\n",
    "\n",
    "years = list(results_claim.keys())\n",
    "results_claim_values = list(results_claim.values())\n",
    "\n",
    "fig, ax = plt.subplots(constrained_layout=True)\n",
    "ax.tick_params(labelsize='x-large')\n",
    "\n",
    "ax.bar(years, results_claim_values, color='blue')\n",
    "\n",
    "ax.set_xlabel('Years')\n",
    "ax.set_ylabel('Spend per claim by year')\n",
    "ax.set_title('Spend per claim by Year')\n",
    "\n",
    "ax.legend()\n",
    "fig.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "6e7834d2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " Year  $0-25  $25-50  $50-100  $100-200  $200-500  $500-1K  $1K-5K  $5K+\n",
      " 2019   2228    1447     1321      1175      1395      939     914   685\n",
      " 2020   2291    1565     1487      1289      1460     1083    1069   807\n",
      " 2021   2462    1723     1589      1417      1521     1199    1227   893\n",
      " 2022   2600    1855     1701      1466      1748     1201    1405  1007\n",
      " 2023   2881    2110     1843      1538      1906     1286    1575  1170\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "\n",
    "# Define price ranges\n",
    "bins = [0, 25, 50, 100, 200, 500, 1000, 5000, float('inf')]\n",
    "labels = ['$0-25', '$25-50', '$50-100', '$100-200', '$200-500', '$500-1K', '$1K-5K', '$5K+']\n",
    "\n",
    "freq_data = []\n",
    "\n",
    "for year in years:\n",
    "    spend_per_claim = csvFile[f'Avg_Spnd_Per_Clm_{year}'].dropna()\n",
    "    spend_per_claim = spend_per_claim[spend_per_claim > 0]\n",
    "    \n",
    "    # Count drugs in each bin\n",
    "    counts = pd.cut(spend_per_claim, bins=bins, labels=labels, right=False).value_counts().sort_index()\n",
    "    \n",
    "    row = {'Year': year}\n",
    "    for label in labels:\n",
    "        row[label] = counts.get(label, 0)\n",
    "    \n",
    "    freq_data.append(row)\n",
    "\n",
    "freq_df = pd.DataFrame(freq_data)\n",
    "print(freq_df.to_string(index=False))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ee4c3e0b",
   "metadata": {},
   "source": [
    "The number of drugs in the 0-100 range increased by approximately 1,800 drugs (37% growth) from 2019 to 2023. However, the number of ultra-expensive drugs (5K+ per claim) increased by 71% - nearly doubling from 685 to 1,170 drugs."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "36978856",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "There are 3474 of unique drugs in the dataset.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "['1st Tier Unifine Pentips',\n",
       " '1st Tier Unifine Pentips Plus',\n",
       " 'Abacavir',\n",
       " 'Abacavir-Lamivudine',\n",
       " 'Abilify',\n",
       " 'Abilify Asimtufii',\n",
       " 'Abilify Maintena',\n",
       " 'Abilify Mycite',\n",
       " 'Abiraterone Acetate',\n",
       " 'Abraxane']"
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Count of unique drugs, manufactures\n",
    "\n",
    "print(f\"There are {csvFile['Brnd_Name'].nunique()} of unique drugs in the dataset.\")\n",
    "csvFile['Brnd_Name'].unique().tolist()[:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0012eebd",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "There are 962 unique names of manufacturers.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "['Overall',\n",
       " 'Owen Mumford Us',\n",
       " 'Cipla USA, Inc.',\n",
       " 'Rising Pharm',\n",
       " 'Mylan',\n",
       " 'Aurobindo Pharm',\n",
       " 'Camber Pharmace',\n",
       " 'Lupin Pharmaceu',\n",
       " 'Laurus Labs Lim',\n",
       " 'Otsuka America',\n",
       " 'AHP',\n",
       " 'Civicascript, L',\n",
       " 'West-Ward/Hikma',\n",
       " 'Bluepoint/Oncop',\n",
       " 'Major Pharmaceu',\n",
       " 'Florida Pharmac',\n",
       " 'Northstar Rx Ll',\n",
       " 'Avkare',\n",
       " 'Novugen Pharma',\n",
       " 'Novadoz Pharmac',\n",
       " 'Amneal Pharmace',\n",
       " \"Dr.Reddy'S Lab\",\n",
       " 'Celltrion USA,',\n",
       " 'Glenmark Pharma',\n",
       " 'Apotex Corp',\n",
       " 'Wockhardt USA L',\n",
       " 'Teva USA',\n",
       " 'BMS-Abraxis Bio',\n",
       " 'Pfizer US Pharm',\n",
       " 'Sun Pharmaceuti',\n",
       " 'Marlex Pharm.',\n",
       " 'Zydus Pharmaceu',\n",
       " 'Bausch Health U',\n",
       " 'Virtus Pharmace',\n",
       " 'Roxane/West-War',\n",
       " 'Avet Pharmaceut',\n",
       " 'Chartwell Rx Ll',\n",
       " 'Strides Pharma',\n",
       " 'Par Pharmaceuti',\n",
       " 'Jg Pharma, Inc.',\n",
       " 'Ani Pharmaceuti',\n",
       " 'Xspire Pharma',\n",
       " 'Leucadia/Hikma',\n",
       " 'Auromedics-Eugi',\n",
       " 'Fresenius Kabi',\n",
       " 'B.Braun',\n",
       " 'Sandoz',\n",
       " 'Hikma Pharmaceu',\n",
       " 'Hi-Tech/Akorn C',\n",
       " 'Eywa Pharma Inc',\n",
       " 'Genus Lifescien',\n",
       " 'Ranbaxy Pharmac',\n",
       " 'Pharm Assoc Inc',\n",
       " 'Mallinckrodt Ph',\n",
       " 'Viona Pharmaceu',\n",
       " 'Advagen Pharma',\n",
       " 'Taro Pharm USA',\n",
       " 'Novitium/Ani Ph',\n",
       " 'Lifestar Pharma',\n",
       " 'Trupharma, LLC.',\n",
       " 'Alembic Pharmac',\n",
       " 'Micro Labs USA,',\n",
       " 'Ingenus Pharmac',\n",
       " 'Accord Healthca',\n",
       " 'Nostrum Laborat',\n",
       " 'Morton Grove Ph',\n",
       " 'Baxter Healthca',\n",
       " 'Amer. Regent',\n",
       " 'Fresenius-Premi*',\n",
       " 'App/Fresenius K',\n",
       " 'Almaject, Inc',\n",
       " 'Perrigo/Padagis',\n",
       " 'Hospira/Pfizer',\n",
       " 'Sagent Pharmace',\n",
       " 'Eisai/ Woodward',\n",
       " 'Woodward Pharma',\n",
       " 'Sigmapharm Labo',\n",
       " 'Genentech, Inc.',\n",
       " 'Genentech, Inc.*',\n",
       " 'Sanofi-Pasteur',\n",
       " 'Horizon/Amgen',\n",
       " 'Actavis/Allerga',\n",
       " 'Takeda Pharmace',\n",
       " 'Allergan Inc.',\n",
       " 'Fresenius-Premi',\n",
       " 'Carlsbad Tech',\n",
       " 'Fougera/Sandoz',\n",
       " 'Actavis/Teva*',\n",
       " 'Vistapharm/Pai',\n",
       " 'Mylan Instituti',\n",
       " 'Padagis',\n",
       " 'Xiromed, LLC',\n",
       " 'Yiling Pharmace',\n",
       " 'Viona Pharmaceu*',\n",
       " 'Quinn-Fpp',\n",
       " 'Emc Pharma, LLC',\n",
       " 'Torrent Pharmac',\n",
       " 'Zydus Pharmaceu*',\n",
       " 'Mylan*',\n",
       " 'Macleods Pharma',\n",
       " 'Cosette Pharmac',\n",
       " 'Westminster Pha',\n",
       " 'Bionpharma Inc.',\n",
       " 'Ranbaxy/Sun Pha',\n",
       " 'Nivagen Pharmac',\n",
       " 'Teva USA*',\n",
       " 'Almirall, LLC',\n",
       " 'Novartis',\n",
       " 'Mylan Spec/Bioc',\n",
       " 'Mayne Pharma In',\n",
       " 'Actavis/Teva',\n",
       " 'Prasco Labs',\n",
       " 'Encube Ethicals',\n",
       " 'Rochester Pharm',\n",
       " 'Teva Pharm',\n",
       " 'Leo Pharma Inc.',\n",
       " 'Seagen Inc.',\n",
       " 'Eli Lilly & Co.',\n",
       " 'Bayer,Pharm Div',\n",
       " 'Corium/Prasco L',\n",
       " 'Sanofi-Aventis',\n",
       " 'Arbor Pharmaceu',\n",
       " 'Glaxosmithkline',\n",
       " 'Diabetic Supply',\n",
       " 'Neos Brands/Ayt',\n",
       " 'Redhill Biophar',\n",
       " 'Mannkind Corpor',\n",
       " 'Shire US Inc.',\n",
       " 'Amgen',\n",
       " 'Teva Specialty',\n",
       " 'Astrazeneca',\n",
       " 'Akorn Inc.',\n",
       " 'Janssen Biotech',\n",
       " 'Galderma Labora',\n",
       " 'Akorn Inc/Thea',\n",
       " 'Helsinn Therape',\n",
       " 'Crown Laborator',\n",
       " 'Derm Ventures,',\n",
       " 'Edenbridge Phar',\n",
       " 'Kedrion Biophar',\n",
       " 'Octapharma USA',\n",
       " 'CSL Behring LLC',\n",
       " 'Grifols',\n",
       " 'Exelan Pharmace',\n",
       " 'Civica, Inc.',\n",
       " 'Quagen Pharmace',\n",
       " 'Sun Pharma Glob',\n",
       " 'Ritedose Pharma',\n",
       " 'Nephron Corp',\n",
       " 'Hi-Tech/Akorn C*',\n",
       " 'AHP*',\n",
       " 'Mutual Pharm Co',\n",
       " 'Global Diabetic',\n",
       " 'Home Aide Diagn',\n",
       " 'Rugby',\n",
       " 'Arise Medical L',\n",
       " 'Hm-Strategic So',\n",
       " 'One Pharmaceuti',\n",
       " 'US Diagnostics',\n",
       " 'Walgreen Co.',\n",
       " 'Specialty Med',\n",
       " 'Fifty50 Pharmac',\n",
       " 'Dynarex Corp.',\n",
       " 'Xpress Medical',\n",
       " 'Phoenix Healthc',\n",
       " 'Sm-Strategic So',\n",
       " 'Simple Diagnost',\n",
       " 'Kroger Co',\n",
       " 'Sdi USA, Inc.',\n",
       " 'CVS',\n",
       " 'Amerisource-Gnp',\n",
       " 'Ultimed Inc',\n",
       " 'Chain Drug',\n",
       " 'Leader',\n",
       " 'Wal-Mart Stores',\n",
       " 'Meijer Inc.',\n",
       " 'Rite Aid Corp.',\n",
       " 'Target Corp',\n",
       " 'Perrigo Diabete',\n",
       " 'Pharmacia-Upjhn',\n",
       " 'Genzyme',\n",
       " 'Impax/Amneal',\n",
       " 'Unichem Pharmac',\n",
       " 'Par Pharm.',\n",
       " 'Arise Pharmaceu',\n",
       " 'Qualitest/Par P',\n",
       " 'Leading Pharma',\n",
       " 'Mckesson Packag',\n",
       " 'Larken Labs',\n",
       " 'Ajanta Pharma L',\n",
       " 'Alcon/Novartis',\n",
       " 'Greenstone LLC.',\n",
       " 'Breckenridge',\n",
       " 'Bausch & Lomb I',\n",
       " 'Monarch Phrm',\n",
       " 'Covis Pharma',\n",
       " 'Athem, LLC',\n",
       " 'Upsher-Smith La',\n",
       " 'Upsher Smith La',\n",
       " 'Astellas Pharma',\n",
       " 'Clover Pharmace',\n",
       " 'Teva Parenteral',\n",
       " 'Avet-Novaplus',\n",
       " 'Biocon Pharma I',\n",
       " 'Vitruvias Thera',\n",
       " 'Cameron Pharmac',\n",
       " 'Amgen USA Inc.',\n",
       " 'Quallent Pharma',\n",
       " 'Oxford Pharmace',\n",
       " 'Ascend Laborato',\n",
       " 'Epic Pharma LLC',\n",
       " 'Biomes Pharmace',\n",
       " 'Legacy Pharmace',\n",
       " 'Bi-Coastal Phar',\n",
       " 'Aci Healthcare',\n",
       " 'Pd-Rx Pharm',\n",
       " 'Caraco/Sun Phar',\n",
       " 'Bluepoint Labor',\n",
       " 'Greenstone/Pras',\n",
       " 'Gavis/Lupin',\n",
       " 'Sarepta Therape',\n",
       " 'USAntibiotics,',\n",
       " 'American Antibi',\n",
       " 'Granules Pharma',\n",
       " 'Lannett Co. Inc',\n",
       " 'X-Gen Pharmaceu',\n",
       " 'Methapharm Inc',\n",
       " 'Sandoz*',\n",
       " 'Sandoz-Novaplus',\n",
       " 'Sandoz-Premier',\n",
       " 'Xellia Pharmace',\n",
       " 'Athenex Pharmac',\n",
       " 'WG Critical Car',\n",
       " 'Piramal Critica',\n",
       " 'Armas Pharmaceu',\n",
       " 'Meitheal Pharma',\n",
       " 'Eugia-Premierpr',\n",
       " 'Acorda Therapeu',\n",
       " 'Alnylam Pharmac',\n",
       " 'Journey Medical',\n",
       " 'Vyne/Journey',\n",
       " 'Sebela Pharmace*',\n",
       " 'B.F Ascher & Co',\n",
       " 'Ascend Therapeu',\n",
       " 'Abbvie US LLC',\n",
       " 'Therapeut/Mayne',\n",
       " 'Casper Pharma L',\n",
       " 'Salix Pharmaceu',\n",
       " 'US World/Supern',\n",
       " 'Viiv Healthcare',\n",
       " 'Rhodes Pharmace',\n",
       " 'Sunovion-Sumito',\n",
       " 'Boehringer Ing.',\n",
       " 'Baxalta US Inc.',\n",
       " 'Kiniksa Pharmac',\n",
       " 'Orapharma',\n",
       " 'Slate Run Pharm',\n",
       " 'Eisai Inc.',\n",
       " 'Insmed Incorpor',\n",
       " 'Solco Healthcar',\n",
       " 'Sky Pharmaceuti',\n",
       " 'Silarx/Lannett',\n",
       " 'Safecor Health',\n",
       " 'Xlcare Pharmace',\n",
       " 'Orchid/Bionphar',\n",
       " 'Alkermes Inc',\n",
       " 'Natco Pharma Us',\n",
       " 'Forest/Allergan',\n",
       " 'Adma Biologics,',\n",
       " 'Organon LLC',\n",
       " 'Arkray USA',\n",
       " 'Burel Pharmaceu',\n",
       " 'Cmp Pharma, Inc',\n",
       " 'International L',\n",
       " 'Radha Pharmaceu',\n",
       " 'Ohm-Sun Pharmac',\n",
       " 'Avpak',\n",
       " 'Kremers/Lannett',\n",
       " 'Cambridge Thera',\n",
       " 'Sciegen Pharmac',\n",
       " 'Gsms, Inc.',\n",
       " 'KVK-Tech, Inc.',\n",
       " 'Gilead Sciences',\n",
       " 'Alcon Laborator',\n",
       " 'Oak Pharmaceuti',\n",
       " 'Hospira/Pfizer*',\n",
       " 'Amer. Regent*',\n",
       " 'Afaxys, Inc.',\n",
       " 'Allegis Pharmac',\n",
       " 'Keryx Biopharma',\n",
       " 'Teva Neuroscien',\n",
       " 'Bd Diabetes/Emb',\n",
       " 'Bd Diabetes',\n",
       " 'Axsome Therapeu',\n",
       " 'Kaleo, Inc.',\n",
       " 'Endo Pharm Inc.',\n",
       " 'GSK/Woodward Ph',\n",
       " 'Biogen-Idec',\n",
       " \"Teva Women's He\",\n",
       " 'Blueprint Medic',\n",
       " 'BMS Primarycare',\n",
       " 'Thea Pharma Inc',\n",
       " 'Oceanside Pharm',\n",
       " 'Sun Pharma Glob*',\n",
       " 'Somerset Therap',\n",
       " 'Apotex Corp*',\n",
       " 'Fosun Pharma Us',\n",
       " 'Solubiomix, LLC',\n",
       " 'Tagi Pharma',\n",
       " 'Novartis/Sandoz',\n",
       " 'Daiichi Sankyo/',\n",
       " 'Fresenius-Novap',\n",
       " 'Becton Dickinso',\n",
       " 'Merck Sharp & D',\n",
       " 'Kartha Pharmace',\n",
       " 'Wilshire Pharma',\n",
       " 'Caraco Pharma I',\n",
       " 'Banner Life Sci',\n",
       " 'Avion Pharmaceu',\n",
       " 'Janssen Product',\n",
       " 'J&J Cons/Kenvue',\n",
       " 'Emd Serono, Inc',\n",
       " 'Melinta Therape*',\n",
       " 'Biodelivery Sci',\n",
       " 'Cephalon,Inc.-T',\n",
       " 'Glaxosmithkline*',\n",
       " 'Aptalis/Allerga',\n",
       " 'Acella Pharmace',\n",
       " 'Aiping Pharmace',\n",
       " 'Excellium Pharm',\n",
       " 'Bayshore Pharma',\n",
       " 'Wyeth/Pfizer',\n",
       " 'Pharmaessentia',\n",
       " 'Oakrum Pharma,',\n",
       " 'Teligent Pharma',\n",
       " 'STI Pharma, LLC',\n",
       " 'Covis-Legacy Ph',\n",
       " 'Eci Pharmaceuti',\n",
       " 'Chiesi USA, Inc',\n",
       " 'Oceanside Pharm*',\n",
       " 'Amneal Pharmace*',\n",
       " 'Arbor/Azurity',\n",
       " 'Alembic Pharmac*',\n",
       " 'UCB Pharma',\n",
       " 'Roche Labs.',\n",
       " 'Duchesnay USA,',\n",
       " 'Fresenius Kabi*',\n",
       " \"Dr.Reddy'S Lab*\",\n",
       " 'Allergan/Botox',\n",
       " 'Array/Pfizer',\n",
       " 'Pacific-Zydus (',\n",
       " 'Tg Therapeutics',\n",
       " 'UCB Pharma*',\n",
       " 'Braeburn Inc.',\n",
       " 'Beigene USA, In',\n",
       " 'Alcon Surgical',\n",
       " 'Astrazeneca/Pra',\n",
       " 'Heritage Pharma',\n",
       " 'Alvogen Inc',\n",
       " 'West-Ward/Hikma*',\n",
       " 'Apnar Pharma, L',\n",
       " 'Global Pharm',\n",
       " 'Method Pharmace',\n",
       " 'TWI Pharmaceuti',\n",
       " 'Sunrise Pharmac',\n",
       " 'Mikart, Inc',\n",
       " 'Seton Pharmaceu',\n",
       " 'Purdue Pharma L',\n",
       " 'Albireo Pharma',\n",
       " 'Centurion Labs',\n",
       " 'Sola Pharmaceut',\n",
       " 'Exelixis, Inc.',\n",
       " 'Pfizer Labs.',\n",
       " 'Pfizer/Viatris',\n",
       " 'Tolmar Inc.',\n",
       " 'Precision Dose',\n",
       " 'Assertio Therap',\n",
       " 'Myokardia, Inc.',\n",
       " 'Intra-Cellular',\n",
       " 'Amici Pharmaceu',\n",
       " 'Orphan Europe/R',\n",
       " 'Jubilant Cadist',\n",
       " 'Amerigen Pharma',\n",
       " 'Foxland Pharmac',\n",
       " 'Biocomp Pharma,',\n",
       " 'Hospira-Novaplu',\n",
       " 'Bpi Labs, LLC',\n",
       " 'Facet Technolog',\n",
       " 'Whele LLC',\n",
       " 'Wallace/Mylan',\n",
       " 'Vensun/Strides',\n",
       " 'Leadiant Biosci',\n",
       " 'Leadiant Biosci*',\n",
       " 'Aphena Pharma S',\n",
       " 'West-Ward-Novap',\n",
       " 'Samson Medical',\n",
       " 'Sagent-Premierp',\n",
       " 'Apotex-Premierp',\n",
       " 'Apotex-Novaplus',\n",
       " 'Hospira-Novaplu*',\n",
       " 'Cephazone Pharm*',\n",
       " 'Sagent Pharmace*',\n",
       " 'Modavar Pharmac',\n",
       " 'Sydon Labs LLC',\n",
       " 'Medstone Pharma',\n",
       " 'Bryant Ranch Pr',\n",
       " 'Cequr Corporati',\n",
       " 'Recordati Rare',\n",
       " 'Travere/Mirum P',\n",
       " 'Xttrium Labs.',\n",
       " 'Dash/Natco Phar',\n",
       " 'Zameer Pharmace',\n",
       " 'Vistapharm',\n",
       " 'Trigen Laborato',\n",
       " 'Cintex Services',\n",
       " 'Manchester/Miru',\n",
       " 'Puracap Laborat',\n",
       " 'Medimetriks Pha',\n",
       " 'Fougera',\n",
       " 'Mylan Specialty',\n",
       " 'Coherus/Sandoz',\n",
       " 'Heron Therapeut',\n",
       " 'Proficient Rx L',\n",
       " 'Rising Pharm*',\n",
       " 'Altaire Pharm',\n",
       " 'Claris/Baxter',\n",
       " 'Caraco Pharm',\n",
       " 'Almatica Pharma',\n",
       " 'Mission Pharm.',\n",
       " 'Ayurax',\n",
       " 'Ferring Ph Inc',\n",
       " 'Solaris Pharma',\n",
       " 'Greenstone LLC.*',\n",
       " 'Glasshouse Phar',\n",
       " 'Fougera/Sandoz*',\n",
       " '3M Espe Dental',\n",
       " 'Ipg Pharmaceuti',\n",
       " 'Epi Health LLC',\n",
       " 'Megalith Pharma',\n",
       " 'Mylan/Aurobindo',\n",
       " 'HLS Therapeutic',\n",
       " 'Tris Pharma Inc',\n",
       " 'Noven Therapeut',\n",
       " 'Slv Pharmaceuti',\n",
       " 'US Pharmaceutic',\n",
       " 'Janssen Pharm.',\n",
       " 'Nalpropion/Curr',\n",
       " 'Vertical Pharm',\n",
       " 'Verastem, Inc.',\n",
       " 'Secura Bio, Inc',\n",
       " 'Waylis Therapeu',\n",
       " 'Uswm, LLC, D.B.',\n",
       " 'Meda/Mylan Spec',\n",
       " 'G1 Therapeutics',\n",
       " 'Astellas Pharma*',\n",
       " 'Ritedose Pharma*',\n",
       " 'Micro Labs USA,*',\n",
       " 'Woodward Pharma*',\n",
       " 'Marnel Pharm.',\n",
       " 'Kyowa Kirin, In',\n",
       " 'Ultragenyx/Kyow',\n",
       " 'Covidien/Kendal',\n",
       " 'Shire/Takeda Ph',\n",
       " 'Merz',\n",
       " 'Orphalan S.A.',\n",
       " 'Virtue Rx',\n",
       " 'SA3, LLC',\n",
       " 'Innovida Pharma',\n",
       " 'Alivio Medical',\n",
       " 'Baxter Healthca*',\n",
       " 'Amneal Bioscien',\n",
       " 'The Chao Center',\n",
       " 'Santarus Inc/Sa',\n",
       " 'Saol/Kamada Ltd',\n",
       " 'Durata/Allergan',\n",
       " 'Elite Laborator',\n",
       " 'Pacific/Greenst',\n",
       " 'Jacobus Pharm.',\n",
       " 'Sagent-Novaplus',\n",
       " 'Meitheal-Novapl',\n",
       " 'Meitheal-Health',\n",
       " 'Xellia-Premierp',\n",
       " 'Be Pharmaceutic',\n",
       " 'Vyera Pharmaceu',\n",
       " 'Acadia Pharmace',\n",
       " 'Ferring Ph Inc*',\n",
       " 'Allergan/Abbvie',\n",
       " 'Pfizer-Novaplus',\n",
       " 'Royal Pharmaceu',\n",
       " 'Puretek Corpora',\n",
       " 'Belcher Pharmac',\n",
       " 'Sun Pharmaceuti*',\n",
       " 'Northstar Rx Ll*',\n",
       " 'Amring-Nordic*',\n",
       " 'Kmm Pharmaceuti',\n",
       " 'IGI Labs, Inc./',\n",
       " 'Fera Pharmaceut',\n",
       " 'Mylan Inst-Nova',\n",
       " 'App-Premierpro',\n",
       " 'Winder Laborato',\n",
       " 'Amerigen/Ani Ph',\n",
       " 'Acetris Health',\n",
       " 'Oryza Pharmaceu',\n",
       " 'International M',\n",
       " 'Biocodex, Inc',\n",
       " 'E5 Pharma',\n",
       " 'Yaral Pharma, I',\n",
       " 'Archis Pharma L',\n",
       " 'Mylan/Archis Ph',\n",
       " 'Trifluent Pharm',\n",
       " 'Ina Pharmaceuti',\n",
       " 'Repharm LLC',\n",
       " 'International B',\n",
       " 'Avkare*',\n",
       " 'Eagle Pharmaceu',\n",
       " 'Entera Health,',\n",
       " 'Emerald Therape',\n",
       " 'Oliva Therapeut',\n",
       " 'Provepharm Inc.',\n",
       " 'Apollo/Provepha',\n",
       " 'Vertical/Avion',\n",
       " 'Winthrop US',\n",
       " 'Hosp/Pfiz-Premi',\n",
       " 'Ultragenyx Phar',\n",
       " 'Akarx, Inc.',\n",
       " 'Macoven Pharmac',\n",
       " 'First Nation Gr',\n",
       " 'Harris Pharm',\n",
       " 'Analog Pharma,',\n",
       " 'Htl-Strefa, S.A',\n",
       " 'Htl-Strefa, Inc',\n",
       " 'H2 Pharma LLC',\n",
       " 'BMS/H2 Pharma L',\n",
       " 'Astrazeneca/Cov',\n",
       " 'Concordia Pharm',\n",
       " 'Ipsen Biopharma',\n",
       " 'Mhc Medical Pro',\n",
       " 'Bd Medical Surg',\n",
       " 'Nomax Inc',\n",
       " 'Theratechnologi',\n",
       " 'Aventura Pharma',\n",
       " 'Rx Elite',\n",
       " 'Scilex Pharmace',\n",
       " 'Omnis Health',\n",
       " 'Ptc Therapeutic',\n",
       " 'Apellis Pharmac',\n",
       " 'Jaymac Pharma',\n",
       " 'Emmaus Medical',\n",
       " 'Daiichi Sankyo,',\n",
       " 'Bioverativ U.S.',\n",
       " 'Hepalink USA, I',\n",
       " 'Amphastar Pharm',\n",
       " 'Veloxis Pharmac',\n",
       " 'Azurity Pharmac',\n",
       " 'Jazz Pharmaceut',\n",
       " 'Validus Pharmac',\n",
       " 'Tersera/Pangea',\n",
       " 'Bausch/Lacer',\n",
       " 'Par-Premier Pro',\n",
       " 'Auromedics-Nova',\n",
       " 'Actavis/Allerga*',\n",
       " 'Ani Pharmaceuti*',\n",
       " 'Versapharm/Akor',\n",
       " 'Provell Pharmac',\n",
       " 'Regeneron Pharm',\n",
       " 'Mitsubishi Tana',\n",
       " 'Kala/Alcon Labo',\n",
       " 'Mylan Instituti*',\n",
       " 'Vanda Pharmaceu',\n",
       " 'Millicent Pharm',\n",
       " 'Creekwood Pharm',\n",
       " 'Austarpharma Ll',\n",
       " 'Specgx LLC',\n",
       " 'Shionogi Pharma',\n",
       " 'Novo Nordisk',\n",
       " 'Travere Therape',\n",
       " 'Zogenix/UCB Pha',\n",
       " 'Catalyst Pharma',\n",
       " 'Azurity-Novaplu',\n",
       " 'Patrin Pharma',\n",
       " 'Alcon/Eyevance',\n",
       " 'Eyevance/Harrow',\n",
       " 'Ibsa Pharma Inc',\n",
       " 'Salerno Pharmac',\n",
       " 'Denmat Holdings',\n",
       " 'Accord Healthca*',\n",
       " 'Time-Cap Labs',\n",
       " 'Aucta Pharmaceu',\n",
       " 'Novadoz-Premier',\n",
       " 'Aveo Pharmaceut',\n",
       " 'Abbott Diabetes',\n",
       " 'Biocon Biologic',\n",
       " 'Scpharmaceutica',\n",
       " 'Sterling-Knight',\n",
       " 'Amicus Therapeu',\n",
       " 'Patriot Pharmac',\n",
       " 'Grifols Therape',\n",
       " 'Sobi-Swedish Or',\n",
       " 'Bio Products La',\n",
       " 'Equaline Vitami',\n",
       " 'Urovant-Sumitom',\n",
       " 'Evoke Pharma, I',\n",
       " 'Nextsource Biot',\n",
       " 'Intra-Sana Labo',\n",
       " 'Fh2 Pharma LLC',\n",
       " 'Supernus/Adamas',\n",
       " 'Braintree/Sebel',\n",
       " 'Assertio/Almati',\n",
       " 'Alk-Abello, Inc',\n",
       " 'Xeris Pharmaceu',\n",
       " 'Innogenix, Inc.',\n",
       " 'West-Ward-Premi',\n",
       " 'Allison Medical',\n",
       " 'Acrotech Biopha',\n",
       " 'Pierre Fabre Ph',\n",
       " 'Meitheal-Premie',\n",
       " 'Meitheal Pharma*',\n",
       " 'Dynavax Technol',\n",
       " 'Chartwell Rx Ll*',\n",
       " 'Slayback Pharma',\n",
       " 'Nobelpharma Ame',\n",
       " 'Wallace/Mylan*',\n",
       " 'Noble Pharmaceu*',\n",
       " 'County/Alvogen*',\n",
       " 'Alvogen Inc*',\n",
       " 'Acella Pharmace*',\n",
       " 'Smith&n/United',\n",
       " 'Ardelyx, Inc',\n",
       " 'Polygen Pharmac',\n",
       " 'Landmark Supply',\n",
       " 'Celgene/BMS',\n",
       " 'Bioxcel Therape',\n",
       " 'Novartis/Harrow',\n",
       " 'Pharmacyclics,',\n",
       " 'Profounda, Inc',\n",
       " 'Sebela Pharmace',\n",
       " 'Heb Grocery Com',\n",
       " 'Egalet/Zyla Lif*',\n",
       " 'Neurocrine Bios',\n",
       " 'Lexicon Pharmac',\n",
       " 'Medtronic Minim',\n",
       " 'Taiho Oncology',\n",
       " \"Exel Int'L Inc.\",\n",
       " \"Sam'S West Inc\",\n",
       " 'American Sales',\n",
       " 'Select Brand',\n",
       " 'Rite Aid-Bd',\n",
       " 'Dinorio Medical',\n",
       " 'Med.Plastic Dev',\n",
       " 'Amag/Covis Phar',\n",
       " 'Alcon/Imprimis',\n",
       " 'Hisun Pharmaceu',\n",
       " 'R-Pharm US',\n",
       " 'Valneva',\n",
       " 'Iveric Bio Inc',\n",
       " 'Incyte Corporat',\n",
       " 'Clarus/Tolmar',\n",
       " 'Pharming Health',\n",
       " 'Ironshore Pharm',\n",
       " 'Amryt/Chiesi',\n",
       " 'Bavarian Nordic',\n",
       " 'Beach Products',\n",
       " 'Dyax Corp./Shir',\n",
       " 'Vertex Pharmace',\n",
       " 'Pharmaderm/Sand',\n",
       " 'Taro Pharm USA*',\n",
       " 'Misemer Pharmac',\n",
       " 'Virtus Pharmace*',\n",
       " 'Fresenius-Novap*',\n",
       " 'Fosun Pharma Us*',\n",
       " 'Athenex Pharmac*',\n",
       " 'Almaject, Inc*',\n",
       " 'Melinta Therape',\n",
       " 'Hikma Specialty',\n",
       " 'Corcept Therape',\n",
       " 'Astrazeneca/Ale',\n",
       " 'Mirati Therapeu',\n",
       " 'Cumberland Phar',\n",
       " 'Biomarin Pharma',\n",
       " 'Sunovion Pharma',\n",
       " 'Camber Pharmace*',\n",
       " 'B.Braun*',\n",
       " 'Owp Pharmaceuti',\n",
       " 'Amring-Nordic',\n",
       " 'Asegua Therapeu',\n",
       " 'Ingenus Pharmac*',\n",
       " 'Prasco/Woodward',\n",
       " 'Partner Therape',\n",
       " 'Burel/Prasco La',\n",
       " 'Omnivium Pharma',\n",
       " 'Novadoz Pharmac*',\n",
       " 'Solco Healthcar*',\n",
       " 'Neolpharma, Inc',\n",
       " 'Akorn Inc.*',\n",
       " 'Sentynl Therapu',\n",
       " 'Meda/Mylan Spec*',\n",
       " 'Dusa/Sun Pharma',\n",
       " 'Teva-Novaplus',\n",
       " 'International M*',\n",
       " 'Huons/Vgyaan',\n",
       " 'Brookfield Phar',\n",
       " 'Seton Pharmaceu*',\n",
       " 'Saol/Amneal Pha',\n",
       " 'Medicore',\n",
       " 'Kowa Pharmaceut',\n",
       " 'Mirum Pharmaceu',\n",
       " 'Agepha Pharma U',\n",
       " 'Carwin Associat',\n",
       " 'West-Ward/Hi-No',\n",
       " 'Sanofi-Premierp',\n",
       " 'Avadel Pharmace',\n",
       " 'Sunvn/Wdwd/Wayl',\n",
       " 'Aurinia Pharma',\n",
       " 'Laboratoire Hra',\n",
       " 'Exela Pharma Sc',\n",
       " 'Amag/Covis Phar*',\n",
       " 'I3 Pharmaceutic',\n",
       " 'Thepharmanetwor',\n",
       " 'Delta Hi-Tech',\n",
       " 'Amphastar-Novap',\n",
       " 'Lifsa Drugs LLC',\n",
       " 'Metcure Pharmac',\n",
       " 'Sallus Laborato',\n",
       " 'Key Therapeutic',\n",
       " 'Amneal-Premier',\n",
       " 'Amneal Bio-Nova',\n",
       " 'App/Fresenius K*',\n",
       " 'New Amer/Melint',\n",
       " 'Baxter-Premierp',\n",
       " 'Prugen Pharmace',\n",
       " 'Cosette Pharmac*',\n",
       " 'Cambridge Senso',\n",
       " 'Cotherix, Inc.',\n",
       " 'Zylera',\n",
       " 'Avalo Therapeut',\n",
       " 'Ranbaxy Pharma',\n",
       " 'Morphosys US In',\n",
       " 'Sherwood',\n",
       " 'Covidien',\n",
       " 'Can-Am/Access C',\n",
       " 'Redhill/Valinor',\n",
       " 'Valinor Pharma',\n",
       " 'Chiasma Inc.',\n",
       " 'Myovant-Sumitom',\n",
       " 'Solstice/Supern',\n",
       " 'Napo Pharmaceut',\n",
       " 'Vgyaan Pharmace',\n",
       " 'Forte Bio-Pharm',\n",
       " 'Mylan/Premierpr',\n",
       " 'Adapt Pharma In',\n",
       " 'Acerus Pharma',\n",
       " 'Parapro LLC',\n",
       " 'Puma Biotechnol',\n",
       " 'Esperion Therap',\n",
       " 'Redmont Pharmac',\n",
       " 'Avondale Pharma',\n",
       " 'Cycle Pharmaceu',\n",
       " 'Pfizer US Pharm*',\n",
       " 'Antares Pharma',\n",
       " 'Poly Pharmaceut',\n",
       " 'Lundbeck Inc.',\n",
       " 'Novo Nordisk-Wa',\n",
       " 'Merck Sharp & D*',\n",
       " 'Collegium Pharm',\n",
       " 'Avanir Pharmace',\n",
       " 'Biohaven Pharma',\n",
       " 'Exeltis USA, In',\n",
       " 'Paratek Pharmac*',\n",
       " 'Major Pharmaceu*',\n",
       " 'Leading Pharma*',\n",
       " 'Bryant Ranch Pr*',\n",
       " 'Intercept Pharm',\n",
       " 'Lifestar Pharma*',\n",
       " 'Bausch & Lomb I*',\n",
       " 'Springworks The',\n",
       " 'Insulet Corpora',\n",
       " 'Avet-Premierpro',\n",
       " 'Neurocrine/Amne',\n",
       " 'Currax Pharmace',\n",
       " 'Actelion Pharma',\n",
       " 'Greer Laborator',\n",
       " 'United Therap',\n",
       " 'Biocryst Pharma',\n",
       " 'Atland Pharmace',\n",
       " 'Galt Pharmaceut',\n",
       " 'Stemline Therap',\n",
       " 'Celgene/Amgen',\n",
       " 'Wraser Pharma',\n",
       " 'Antares/Otter',\n",
       " 'Nextgen Pharmac',\n",
       " 'Egalet/Zyla Lif',\n",
       " 'Global Blood Th',\n",
       " 'Dompe US, Inc',\n",
       " 'Supernus Pharma',\n",
       " 'Affordable Phar',\n",
       " 'Pharmaand Gmbh',\n",
       " 'Teva-Premierpro',\n",
       " 'Vivus',\n",
       " 'California Phar',\n",
       " 'Medline Indus.',\n",
       " 'Medicine Shop',\n",
       " 'Pharmacy Value',\n",
       " 'Platinum Ventur',\n",
       " 'Colgate Oral Ph',\n",
       " 'Indivior Inc.',\n",
       " 'Digestive Care',\n",
       " 'Pfizer-Premierp',\n",
       " 'Graxcell Pharma',\n",
       " 'Qualitest',\n",
       " 'Bioramo',\n",
       " 'Valeant/Paragon',\n",
       " 'Paragon/Bausch',\n",
       " 'Evofem Bioscien',\n",
       " 'Fresenius Medic',\n",
       " 'Biogen-Idec*',\n",
       " 'Perrigo Co.',\n",
       " 'Kesin Pharma',\n",
       " 'Adare Pharmaceu',\n",
       " 'Sanofi/Regenero',\n",
       " 'Vbi Vaccines (D',\n",
       " 'Wyeth/Pfizer*',\n",
       " 'Sancilio & Comp',\n",
       " 'Nnodum Corp',\n",
       " 'Tersera Therape',\n",
       " 'Prodigy Diabete',\n",
       " 'Banner Pharmaca',\n",
       " 'Virtus/Acertis',\n",
       " 'Acertis Pharmac',\n",
       " 'Sandoz Inc.',\n",
       " 'Dista Labs',\n",
       " 'Nova Laboratori',\n",
       " 'Agios Pharmaceu',\n",
       " 'Deciphera Pharm',\n",
       " 'Averitas Pharma',\n",
       " 'Idorsia Pharmac',\n",
       " 'GSK/Bavarian No',\n",
       " 'Medexus Pharma,',\n",
       " 'Raya Pharmaceut',\n",
       " 'Opko Pharmaceut',\n",
       " 'Ferring Pharmac',\n",
       " 'Amneal Bioscien*',\n",
       " 'Salix Pharmaceu*',\n",
       " 'Amylyx Pharmace',\n",
       " 'Cypress Pharm.',\n",
       " 'Guardian Chem.',\n",
       " 'Rigel Pharmaceu',\n",
       " 'Kadmon/Sanofi-A',\n",
       " 'Epi Health/Mayn',\n",
       " 'Sanofi-Aventis*',\n",
       " 'Spectrum Pharma',\n",
       " 'Scov3 LLC',\n",
       " 'Mallinckrodt Br',\n",
       " 'Protega Pharmac',\n",
       " 'Clovis/Pharmaan',\n",
       " 'Kyowa/Cumberlan',\n",
       " 'Novartis*',\n",
       " 'Laser Pharmaceu',\n",
       " 'Medunik USA',\n",
       " 'Pernix Therapeu',\n",
       " 'Nabriva Therape*',\n",
       " 'Reata Pharmaceu',\n",
       " 'Abbvie US LLC*',\n",
       " 'Sarfez Pharmace',\n",
       " 'Icu Medical Inc',\n",
       " 'Grifols-Icu Med',\n",
       " 'Sheffield Pharm',\n",
       " 'Method Pharmace*',\n",
       " 'Alexion Pharmac',\n",
       " 'Lupin Pharma',\n",
       " 'Phar-Prep/Pfize',\n",
       " 'Aprecia Pharmac',\n",
       " 'Cmp Pharma, Inc*',\n",
       " 'Janssen Biotech*',\n",
       " 'West Therapeuti',\n",
       " 'Qol Medical',\n",
       " 'Braintree Labs.',\n",
       " 'Perrigo/Padagis*',\n",
       " 'Vista Pharmaceu',\n",
       " 'Ani Phar/Prasco',\n",
       " 'Gsms, Inc.*',\n",
       " 'Gilead Sciences*',\n",
       " 'Jazz/Axsome',\n",
       " 'BMS',\n",
       " 'Aquestive/Otter',\n",
       " 'Glenmark Pharma*',\n",
       " 'Bausch Health U*',\n",
       " 'Calliditas Ther',\n",
       " 'Chemocentryx/Am',\n",
       " 'Epizyme Inc/Ips',\n",
       " 'Akcea Therapeut',\n",
       " 'Noden-Lxo US In',\n",
       " 'Noden Pharma D.',\n",
       " \"Int'L Ethical\",\n",
       " 'Terumo',\n",
       " 'Auxilium/Endo P',\n",
       " 'Vistapharm/Azur',\n",
       " 'Servier Pharmac',\n",
       " 'Itf Pharma, Inc',\n",
       " 'Antares/Verity',\n",
       " 'Up-Sm/Tonix Pha',\n",
       " 'GSK Consumer He',\n",
       " 'Verity Pharmace',\n",
       " 'Saptalis Pharma',\n",
       " 'Long Grove Phar',\n",
       " 'Medecor Pharma',\n",
       " 'Crown Therap/Ma',\n",
       " 'Impel/Jn Bidco',\n",
       " 'Nipro Diag/Triv',\n",
       " 'Trividia Health',\n",
       " 'Synergy/Bausch',\n",
       " 'Qed Therapeutic',\n",
       " 'Wyeth-Prepr/Pfi',\n",
       " 'Radius Health,',\n",
       " 'Oyster Point Ph',\n",
       " 'Coherus Bioscie',\n",
       " 'Boca Medical',\n",
       " 'Quality Medical',\n",
       " 'Aurora Health.',\n",
       " 'Bantry Pharma,',\n",
       " 'Edwards Pharm.',\n",
       " 'Ohm Labs.',\n",
       " 'Genentech/Wayli',\n",
       " 'Neurelis Inc.',\n",
       " 'Retractable Tec',\n",
       " 'Amarin Pharma I',\n",
       " 'Relypsa/Vifor P',\n",
       " 'Doak Derm.',\n",
       " 'Horizon Pharma',\n",
       " 'Nestle Nutritio',\n",
       " 'Bayer Inc.',\n",
       " 'Mycovia Pharmac',\n",
       " 'Cti/Sobi',\n",
       " 'Phathom Pharmac',\n",
       " 'Aimmune Therape',\n",
       " 'Dermavant Scien',\n",
       " 'Krystal Biotech',\n",
       " 'Argenx US, Inc',\n",
       " 'Harmony Bioscie',\n",
       " 'US Worldmeds',\n",
       " 'Sk Life Science',\n",
       " 'Tarsus Pharmace',\n",
       " 'Tetraphase Phar',\n",
       " 'Optinose US, In',\n",
       " 'Shire/Novartis',\n",
       " 'Novartis/Bausch',\n",
       " 'Karyopharm Ther',\n",
       " 'Eyepoint Pharma',\n",
       " 'Zealand Ph/Novo',\n",
       " 'Promius/Upsher-',\n",
       " 'Allergan/Nestle',\n",
       " 'Pacira Pharmace',\n",
       " 'Flexion Therape',\n",
       " \"Dr. Reddy'S-Pre\",\n",
       " \"Dr. Reddy'S-Nov\",\n",
       " 'Aralez/Xspire P',\n",
       " 'Arcutis Biother',\n",
       " 'Pfizer/Baxter',\n",
       " 'Marinus Pharmac',\n",
       " 'Orexo US, Inc.',\n",
       " 'Adc Therapeutic',\n",
       " 'Medicure Intern',\n",
       " 'Eli Lilly & Co.*']"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print(f\"There are {csvFile['Mftr_Name'].nunique()} unique names of manufacturers.\")\n",
    "\n",
    "csvFile['Mftr_Name'].unique().tolist()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "f83fbb25",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/wy/v92nv28111j7vk4ynsyxm2700000gn/T/ipykernel_891/3123641603.py:17: UserWarning: No artists with labels found to put in legend.  Note that artists whose label start with an underscore are ignored when legend() is called with no argument.\n",
      "  ax.legend()\n",
      "/var/folders/wy/v92nv28111j7vk4ynsyxm2700000gn/T/ipykernel_891/3123641603.py:18: UserWarning: FigureCanvasAgg is non-interactive, and thus cannot be shown\n",
      "  fig.show()\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Display the results in a bar chart\n",
    "\n",
    "years = list(results.keys())\n",
    "kpi_values = list(results.values())\n",
    "\n",
    "fig, ax = plt.subplots(constrained_layout=True)\n",
    "ax.tick_params(labelsize='x-large')\n",
    "\n",
    "ax.bar(years, kpi_values, color='blue')\n",
    "\n",
    "ax.set_xlabel('Years')\n",
    "ax.set_ylabel('Price per dose unit (weighted) by year')\n",
    "ax.set_title('Price per Dose Unit (Weighted) by Year')\n",
    "\n",
    "ax.legend()\n",
    "fig.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d4a00160",
   "metadata": {},
   "source": [
    "As we can see based on the bar chart, the price per unit has been increasing since 2019. \n",
    "\n",
    "Next, we will calculate the YoY change."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d5935c35",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "3.55\n",
      "7.43\n",
      "6.91\n",
      "9.95\n"
     ]
    }
   ],
   "source": [
    "# Calculate the difference between consecutive years\n",
    "\n",
    "# Calculate the average increase per year\n",
    "value_list = list(results.values())\n",
    "\n",
    "for i in range(1, len(value_list)):\n",
    "    result = round((value_list[i] - value_list[i-1])/ value_list[i-1] * 100, 2)\n",
    "    print(result)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "85eb7811",
   "metadata": {},
   "source": [
    "As KPI is increasing each year, the YoY changes reflect that.\n",
    "\n",
    "Next, we will calculate CAGR (Compound Annual Growth Rate)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7b505126",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "np.float64(0.06936605042133781)"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "CAGR = (value_list[-1]/value_list[0])**(1/4)-1\n",
    "CAGR "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "43b13a90",
   "metadata": {},
   "source": [
    "Drug costs are growing consistently year-over-year, with a CAGR of 6.94% from 2019â€“2023. This sustained increase may be driven by factors such as inflation, manufacturing cost pressures, or shifts in drug mix (brand vs. generic)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "25f65385",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Top 20 Drugs by Spending in 2019 ($ Billions) ===\n",
      "Brnd_Name\n",
      "Eliquis              14.61\n",
      "Revlimid              9.35\n",
      "Xarelto               8.15\n",
      "Januvia               7.07\n",
      "Lantus Solostar       4.99\n",
      "Imbruvica             4.88\n",
      "Trulicity             4.55\n",
      "Lyrica                4.05\n",
      "Symbicort             4.03\n",
      "Novolog Flexpen       3.69\n",
      "Ibrance               3.65\n",
      "Humira Pen            3.50\n",
      "Levemir Flextouch     3.24\n",
      "Victoza 3-Pak         3.05\n",
      "Advair Diskus         2.90\n",
      "Jardiance             2.90\n",
      "Myrbetriq             2.89\n",
      "Xtandi                2.84\n",
      "Restasis              2.71\n",
      "Breo Ellipta          2.68\n",
      "Name: Tot_Spndng_2019, dtype: float64\n",
      "\n",
      "=== Top 20 Drugs by Spending in 2020 ($ Billions) ===\n",
      "Brnd_Name\n",
      "Eliquis              19.87\n",
      "Revlimid             10.71\n",
      "Xarelto               9.40\n",
      "Januvia               7.73\n",
      "Trulicity             6.57\n",
      "Imbruvica             5.93\n",
      "Lantus Solostar       5.33\n",
      "Jardiance             4.75\n",
      "Humira(Cf) Pen        4.34\n",
      "Ibrance               4.22\n",
      "Symbicort             3.96\n",
      "Xtandi                3.94\n",
      "Novolog Flexpen       3.69\n",
      "Biktarvy              3.55\n",
      "Myrbetriq             3.50\n",
      "Levemir Flextouch     3.11\n",
      "Victoza 3-Pak         3.09\n",
      "Breo Ellipta          3.01\n",
      "Trelegy Ellipta       2.98\n",
      "Ozempic               2.91\n",
      "Name: Tot_Spndng_2020, dtype: float64\n",
      "\n",
      "=== Top 20 Drugs by Spending in 2021 ($ Billions) ===\n",
      "Brnd_Name\n",
      "Eliquis            25.15\n",
      "Revlimid           11.79\n",
      "Xarelto            10.45\n",
      "Trulicity           9.40\n",
      "Januvia             8.12\n",
      "Jardiance           7.47\n",
      "Imbruvica           6.30\n",
      "Humira(Cf) Pen      5.81\n",
      "Lantus Solostar     5.66\n",
      "Ozempic             5.24\n",
      "Xtandi              4.82\n",
      "Trelegy Ellipta     4.79\n",
      "Biktarvy            4.40\n",
      "Myrbetriq           3.98\n",
      "Symbicort           3.90\n",
      "Ibrance             3.78\n",
      "Novolog Flexpen     3.64\n",
      "Entresto            3.45\n",
      "Restasis            3.26\n",
      "Pomalyst            3.19\n",
      "Name: Tot_Spndng_2021, dtype: float64\n",
      "\n",
      "=== Top 20 Drugs by Spending in 2022 ($ Billions) ===\n",
      "Brnd_Name\n",
      "Eliquis            30.44\n",
      "Trulicity          12.45\n",
      "Revlimid           11.87\n",
      "Jardiance          11.70\n",
      "Xarelto            11.55\n",
      "Ozempic             9.26\n",
      "Januvia             8.20\n",
      "Humira(Cf) Pen      7.39\n",
      "Trelegy Ellipta     6.68\n",
      "Lantus Solostar     5.75\n",
      "Imbruvica           5.71\n",
      "Biktarvy            5.41\n",
      "Farxiga             5.17\n",
      "Entresto            4.98\n",
      "Xtandi              4.87\n",
      "Stelara*            4.68\n",
      "Myrbetriq           4.51\n",
      "Symbicort           3.93\n",
      "Ibrance             3.90\n",
      "Novolog Flexpen     3.68\n",
      "Name: Tot_Spndng_2022, dtype: float64\n",
      "\n",
      "=== Top 20 Drugs by Spending in 2023 ($ Billions) ===\n",
      "Brnd_Name\n",
      "Eliquis             36.55\n",
      "Ozempic             18.39\n",
      "Jardiance           17.68\n",
      "Trulicity           14.73\n",
      "Xarelto             12.62\n",
      "Trelegy Ellipta      8.91\n",
      "Humira(Cf) Pen       8.84\n",
      "Farxiga              8.68\n",
      "Januvia              8.18\n",
      "Revlimid             7.72\n",
      "Entresto             6.86\n",
      "Lantus Solostar      6.31\n",
      "Biktarvy             6.30\n",
      "Stelara*             5.98\n",
      "Xtandi               5.20\n",
      "Myrbetriq            5.02\n",
      "Imbruvica            4.74\n",
      "Mounjaro             4.72\n",
      "Enbrel Sureclick     4.11\n",
      "Ibrance              4.04\n",
      "Name: Tot_Spndng_2023, dtype: float64\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "\n",
    "top20_by_year = {}\n",
    "\n",
    "for year in years:\n",
    "    # Group by drug name and sum spending for that year\n",
    "    drug_spending = csvFile.groupby('Brnd_Name')[f'Tot_Spndng_{year}'].sum()\n",
    "    \n",
    "    # Get top 20\n",
    "    top20 = drug_spending.nlargest(20)\n",
    "    \n",
    "    # Convert to billions for readability\n",
    "    top20_billions = (top20 / 1e9).round(2)\n",
    "    \n",
    "    top20_by_year[year] = top20_billions\n",
    "\n",
    "# Display results\n",
    "for year in years:\n",
    "    print(f\"\\n=== Top 20 Drugs by Spending in {year} ($ Billions) ===\")\n",
    "    print(top20_by_year[year])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5238da60",
   "metadata": {},
   "source": [
    "The same drugs dominate spending year-over-year. These top 20 drugs accounted for 91B in 2019 and 214B in 2023, representing a 135% increase.\n",
    "\n",
    "Notably, Eliquis spending increased 150%, rising from 14.6B in 2019 to 36.5B in 2023.\n",
    "\n",
    "The top 3 drugs in 2023â€”Eliquis, Ozempic, and Jardianceâ€”represent 72.6B in spending alone.\n",
    "\n",
    "Several new drugs entered the top 20 by 2023 that weren't present in 2019, such as Farxiga and Trelegy Ellipta.\n",
    "\n",
    "Conversely, Lyrica dropped out of the top 20 after ranking 8th in 2019 (4.05B), likely due to patent expiration and generic competition.\n",
    "Revlimid fell from 2nd to 10th place between 2019 and 2023.\n",
    "\n",
    "There is growing demand for diabetes drugs: in 2019, there were 4-5 diabetes medications in the top 20, but by 2023, this increased to 8 drugs.\n",
    "\n",
    "Meanwhile, cancer drugs are declining in rank."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "08799fd9",
   "metadata": {},
   "outputs": [],
   "source": [
    "# KPI: manufacturer share of total spend\n",
    "\n",
    "# Group spending by manufacturer for each year, then sum total spending across all manufacturers per year."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "8dd7e14e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{2019: np.float64(357882769075.67004),\n",
       " 2020: np.float64(392708609310.14),\n",
       " 2021: np.float64(429548317774.91003),\n",
       " 2022: np.float64(480625017491.22003),\n",
       " 2023: np.float64(551849041101.75)}"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mftr_spending_detail = {}\n",
    "\n",
    "for year in years:\n",
    "   spending = round(csvFile.groupby('Mftr_Name')[f'Tot_Spndng_{year}'].sum(), 2)\n",
    "   mftr_spending_detail[year] = spending\n",
    "\n",
    "\n",
    "mftr_spending_total = {}\n",
    "for year in years:\n",
    "   result = mftr_spending_detail[year].sum()\n",
    "   mftr_spending_total[year] = result\n",
    "\n",
    "mftr_spending_total"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "77e8cc69",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{2019: Mftr_Name\n",
       " 3M Espe Dental      0.0000\n",
       " AHP                 0.0008\n",
       " AHP*                0.0000\n",
       " Abbott Diabetes     0.0000\n",
       " Abbvie US LLC       1.6588\n",
       "                      ...  \n",
       " Zealand Ph/Novo     0.0000\n",
       " Zogenix/UCB Pha     0.0000\n",
       " Zydus Pharmaceu     0.3648\n",
       " Zydus Pharmaceu*    0.0386\n",
       " Zylera              0.0001\n",
       " Name: Tot_Spndng_2019, Length: 962, dtype: float64,\n",
       " 2020: Mftr_Name\n",
       " 3M Espe Dental      0.0000\n",
       " AHP                 0.0004\n",
       " AHP*                0.0000\n",
       " Abbott Diabetes     0.0000\n",
       " Abbvie US LLC       1.6992\n",
       "                      ...  \n",
       " Zealand Ph/Novo     0.0000\n",
       " Zogenix/UCB Pha     0.0001\n",
       " Zydus Pharmaceu     0.3613\n",
       " Zydus Pharmaceu*    0.0447\n",
       " Zylera              0.0001\n",
       " Name: Tot_Spndng_2020, Length: 962, dtype: float64,\n",
       " 2021: Mftr_Name\n",
       " 3M Espe Dental      0.0000\n",
       " AHP                 0.0002\n",
       " AHP*                0.0000\n",
       " Abbott Diabetes     0.0000\n",
       " Abbvie US LLC       1.8135\n",
       "                      ...  \n",
       " Zealand Ph/Novo     0.0000\n",
       " Zogenix/UCB Pha     0.0004\n",
       " Zydus Pharmaceu     0.3375\n",
       " Zydus Pharmaceu*    0.0423\n",
       " Zylera              0.0001\n",
       " Name: Tot_Spndng_2021, Length: 962, dtype: float64,\n",
       " 2022: Mftr_Name\n",
       " 3M Espe Dental      0.0000\n",
       " AHP                 0.0001\n",
       " AHP*                0.0000\n",
       " Abbott Diabetes     0.0000\n",
       " Abbvie US LLC       1.9819\n",
       "                      ...  \n",
       " Zealand Ph/Novo     0.0000\n",
       " Zogenix/UCB Pha     0.0015\n",
       " Zydus Pharmaceu     0.2970\n",
       " Zydus Pharmaceu*    0.0369\n",
       " Zylera              0.0001\n",
       " Name: Tot_Spndng_2022, Length: 962, dtype: float64,\n",
       " 2023: Mftr_Name\n",
       " 3M Espe Dental      0.0000\n",
       " AHP                 0.0002\n",
       " AHP*                0.0000\n",
       " Abbott Diabetes     0.0000\n",
       " Abbvie US LLC       2.0913\n",
       "                      ...  \n",
       " Zealand Ph/Novo     0.0000\n",
       " Zogenix/UCB Pha     0.0033\n",
       " Zydus Pharmaceu     0.2916\n",
       " Zydus Pharmaceu*    0.0303\n",
       " Zylera              0.0000\n",
       " Name: Tot_Spndng_2023, Length: 962, dtype: float64}"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mftr_share_by_year = {}\n",
    "for year in years:\n",
    "    mftr_shares = round(mftr_spending_detail[year]/ mftr_spending_total[year] * 100, 4)\n",
    "    mftr_share_by_year[year] = mftr_shares\n",
    "\n",
    "mftr_share_by_year"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "edfb9de8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Overall'"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mftr_share_by_year[2023].idxmax()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "1ff340d6",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2019 Manufacturer: Novo Nordisk, Share: 2.6412.\n",
      "2019 Manufacturer: BMS Primarycare, Share: 2.2687.\n",
      "2019 Manufacturer: Glaxosmithkline, Share: 2.1485.\n",
      "2019 Manufacturer: Eli Lilly & Co., Share: 2.0531.\n",
      "2019 Manufacturer: Janssen Pharm., Share: 2.0235.\n",
      "2020 Manufacturer: BMS Primarycare, Share: 2.7631.\n",
      "2020 Manufacturer: Novo Nordisk, Share: 2.649.\n",
      "2020 Manufacturer: Boehringer Ing., Share: 2.2232.\n",
      "2020 Manufacturer: Eli Lilly & Co., Share: 2.1425.\n",
      "2020 Manufacturer: Glaxosmithkline, Share: 2.129.\n",
      "2021 Manufacturer: BMS Primarycare, Share: 3.1599.\n",
      "2021 Manufacturer: Novo Nordisk, Share: 2.7357.\n",
      "2021 Manufacturer: Boehringer Ing., Share: 2.4529.\n",
      "2021 Manufacturer: Eli Lilly & Co., Share: 2.3325.\n",
      "2021 Manufacturer: Glaxosmithkline, Share: 2.0392.\n",
      "2022 Manufacturer: BMS Primarycare, Share: 3.4088.\n",
      "2022 Manufacturer: Novo Nordisk, Share: 2.9143.\n",
      "2022 Manufacturer: Boehringer Ing., Share: 2.6875.\n",
      "2022 Manufacturer: Eli Lilly & Co., Share: 2.4717.\n",
      "2022 Manufacturer: Astrazeneca, Share: 2.0515.\n",
      "2023 Manufacturer: BMS Primarycare, Share: 3.5506.\n",
      "2023 Manufacturer: Novo Nordisk, Share: 3.4328.\n",
      "2023 Manufacturer: Eli Lilly & Co., Share: 2.8828.\n",
      "2023 Manufacturer: Boehringer Ing., Share: 2.8481.\n",
      "2023 Manufacturer: Glaxosmithkline, Share: 2.275.\n"
     ]
    }
   ],
   "source": [
    "mftr_share_by_year = {}\n",
    "\n",
    "for year in years:\n",
    "    mftr_shares = round(mftr_spending_detail[year]/ mftr_spending_total[year] * 100, 4)\n",
    "    mftr_share_by_year[year] = mftr_shares\n",
    "\n",
    "    filtered_max_dict = {k: v for k, v in mftr_share_by_year[year].items() if \n",
    "                     k != 'Overall'}\n",
    "    # print(f'{year}')\n",
    "\n",
    "    for i in range(1, 6):\n",
    "        max_mftr = max(filtered_max_dict, key=filtered_max_dict.get)\n",
    "        max_share = filtered_max_dict[max_mftr]\n",
    "        print(f'{year} Manufacturer: {max_mftr}, Share: {max_share}.')\n",
    "        del filtered_max_dict[max_mftr]\n",
    "   "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4ffcb458",
   "metadata": {},
   "source": [
    "Novo Nordisk shows consistent year-over-year growth in market share, increasing from 2.64% in 2020 to 3.43% in 2023. BMS Primarycare dominates the market, maintaining the #1 position from 2020 onwards with shares ranging from 2.76% to 3.55%."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "de363d25",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2019: Manufacturer: Novo Nordisk, Share: 2.6412\n",
      "2019: Manufacturer: BMS Primarycare, Share: 2.2687\n",
      "2019: Manufacturer: Glaxosmithkline, Share: 2.1485\n",
      "2019: Manufacturer: Eli Lilly & Co., Share: 2.0531\n",
      "2019: Manufacturer: Janssen Pharm., Share: 2.0235\n"
     ]
    }
   ],
   "source": [
    "filtered_2019 = {k: v for k, v in mftr_share_by_year[2019].items() if \n",
    "                 k != 'Overall'}\n",
    "\n",
    "for i in range(1,6):\n",
    "    max_mftr_2019 = max(filtered_2019, key=filtered_2019.get)\n",
    "    max_share_2019 = filtered_2019[max_mftr_2019]\n",
    "\n",
    "    print(f'2019: Manufacturer: {max_mftr_2019}, Share: {max_share_2019}')\n",
    "\n",
    "    del filtered_2019[max_mftr_2019]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "c648f698",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "np.False_"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "# 'Brnd_Name', 'Gnrc_Name', \n",
    "\n",
    "csvFile['Brnd_Name'].unique()\n",
    "\n",
    "csvFile['Brnd_Name'].isnull().any()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "fd8653a2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "3474"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "csvFile['Brnd_Name'].nunique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "2a2d85f3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1938"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "csvFile['Gnrc_Name'].nunique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "9f85beff",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "np.False_"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(csvFile['Gnrc_Name'])\n",
    "\n",
    "csvFile['Gnrc_Name'].isnull().any()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "4f55d6d3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "count    10104.000000\n",
       "mean       176.391369\n",
       "std       1494.579906\n",
       "min          0.000232\n",
       "25%          0.462640\n",
       "50%          1.973185\n",
       "75%         11.992071\n",
       "max      40190.064683\n",
       "Name: Avg_Spnd_Per_Dsg_Unt_Wghtd_2019, dtype: float64"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "csvFile['Avg_Spnd_Per_Dsg_Unt_Wghtd_2019'].describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "2885aeb5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 2000x400 with 5 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "\n",
    "fig, axes = plt.subplots(1, 5, figsize=(20,4))\n",
    "\n",
    "\n",
    "for i, year in enumerate(years):\n",
    "    axes[i].hist(csvFile[f'Avg_Spnd_Per_Dsg_Unt_Wghtd_{year}'], bins=50)\n",
    "    axes[i].set_title(f'{year}')\n",
    "    axes[i].set_xlabel('Price per dose unit')\n",
    "    axes[i].set_ylabel('Count')\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "d60b850b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "drug_type\n",
      "Brand      9485\n",
      "Generic    4824\n",
      "Name: count, dtype: int64\n"
     ]
    }
   ],
   "source": [
    "csvFile['drug_type'] = csvFile.apply(\n",
    "    lambda row: 'Generic' if row['Brnd_Name'].lower() == row['Gnrc_Name'].lower()\n",
    "    else 'Brand', axis=1)\n",
    "\n",
    "print(csvFile['drug_type'].value_counts())"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "861273e7",
   "metadata": {},
   "source": [
    "Drugs are classified as generic if the brand name matches the generic name; otherwise, they're classified as brand drugs."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "c59652ed",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2019: Brand 88.30%, Generic: 11.70%\n",
      "2020: Brand 88.97%, Generic: 11.03%\n",
      "2021: Brand 89.73%, Generic: 10.27%\n",
      "2022: Brand 90.04%, Generic: 9.96%\n",
      "2023: Brand 90.64%, Generic: 9.36%\n"
     ]
    }
   ],
   "source": [
    "for year in years:\n",
    "    brand_spending = csvFile[csvFile['drug_type'] == 'Brand'][f'Tot_Spndng_{year}'].sum()\n",
    "    generic_spending = csvFile[csvFile['drug_type'] == 'Generic'][f'Tot_Spndng_{year}'].sum()\n",
    "\n",
    "    total_spending = brand_spending + generic_spending\n",
    "\n",
    "    brand_share = (brand_spending/ total_spending) * 100\n",
    "    generic_share = (generic_spending/ total_spending) * 100\n",
    "\n",
    "    print(f'{year}: Brand {brand_share:.2f}%, Generic: {generic_share:.2f}%')"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "venv (3.11.14)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.14"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
